515 related articles for article (PubMed ID: 15960552)
1. The economics of topical immunomodulators for the treatment of atopic dermatitis.
Abramovits W; Boguniewicz M; Paller AS; Whitaker-Worth DL; Prendergast MM; Tokar M; Tong KB
Pharmacoeconomics; 2005; 23(6):543-66. PubMed ID: 15960552
[TBL] [Abstract][Full Text] [Related]
2. Efficacy and economics of topical calcineurin inhibitors for the treatment of atopic dermatitis.
Abramovits W; Hung P; Tong KB
Am J Clin Dermatol; 2006; 7(4):213-22. PubMed ID: 16901181
[TBL] [Abstract][Full Text] [Related]
3. [Topical immunomodulators, such as tacrolimus and pimecrolimus, in the treatment of atopic dermatitis].
de Bruin-Weller MS; Bruijnzeel-Koomen CA
Ned Tijdschr Geneeskd; 2005 May; 149(20):1096-100. PubMed ID: 15932135
[TBL] [Abstract][Full Text] [Related]
4. The effectiveness and cost-effectiveness of pimecrolimus and tacrolimus for atopic eczema: a systematic review and economic evaluation.
Garside R; Stein K; Castelnuovo E; Pitt M; Ashcroft D; Dimmock P; Payne L
Health Technol Assess; 2005 Jul; 9(29):iii, xi-xiii,1-230. PubMed ID: 16022804
[TBL] [Abstract][Full Text] [Related]
5. Topical pimecrolimus: a review of its clinical potential in the management of atopic dermatitis.
Wellington K; Jarvis B
Drugs; 2002; 62(5):817-40. PubMed ID: 11929333
[TBL] [Abstract][Full Text] [Related]
6. Spotlight on topical pimecrolimus in atopic dermatitis.
Wellington K; Jarvis B
Am J Clin Dermatol; 2002; 3(6):435-8. PubMed ID: 12113651
[TBL] [Abstract][Full Text] [Related]
7. Safety and efficacy of topical calcineurin inhibitors in the treatment of childhood atopic dermatitis.
Breuer K; Werfel T; Kapp A
Am J Clin Dermatol; 2005; 6(2):65-77. PubMed ID: 15799678
[TBL] [Abstract][Full Text] [Related]
8. Effect of sequential applications of topical tacrolimus and topical corticosteroids in the treatment of pediatric atopic dermatitis: an open-label pilot study.
Kubota Y; Yoneda K; Nakai K; Katsuura J; Moriue T; Matsuoka Y; Miyamoto I; Ohya Y
J Am Acad Dermatol; 2009 Feb; 60(2):212-7. PubMed ID: 19027990
[TBL] [Abstract][Full Text] [Related]
9. Corticosteroid therapy in the treatment of pediatric patients with atopic dermatitis.
Fröschl B; Arts D; Leopold C
GMS Health Technol Assess; 2007 Sep; 3():Doc09. PubMed ID: 21289943
[TBL] [Abstract][Full Text] [Related]
10. Therapy of atopic eczema.
Werfel T; Claes C; Kulp W; Greiner W; von der Schulenburg JM
GMS Health Technol Assess; 2006 Oct; 2():Doc19. PubMed ID: 21289970
[TBL] [Abstract][Full Text] [Related]
11. Topical pimecrolimus: a review of its use in the management of pediatric atopic dermatitis.
Yang LP; Curran MP
Paediatr Drugs; 2009; 11(6):407-26. PubMed ID: 19877726
[TBL] [Abstract][Full Text] [Related]
12. Spotlight on topical pimecrolimus in pediatric atopic dermatitis.
Yang LP; Curran MP
Am J Clin Dermatol; 2010; 11(4):295-8. PubMed ID: 20509720
[TBL] [Abstract][Full Text] [Related]
13. Topical noncorticosteroid immunomodulation in the treatment of atopic dermatitis.
Reitamo S; Remitz A; Kyllönen H; Saarikko J
Am J Clin Dermatol; 2002; 3(6):381-8. PubMed ID: 12113647
[TBL] [Abstract][Full Text] [Related]
14. Comparative effectiveness of topical calcineurin inhibitors in adult patients with atopic dermatitis.
Frankel HC; Qureshi AA
Am J Clin Dermatol; 2012 Apr; 13(2):113-23. PubMed ID: 22263704
[TBL] [Abstract][Full Text] [Related]
15. Cost-effectiveness analysis of tacrolimus ointment versus high-potency topical corticosteroids in adults with moderate to severe atopic dermatitis.
Ellis CN; Drake LA; Prendergast MM; Abramovits W; Boguniewicz M; Daniel CR; Lebwohl M; Paller AS; Stevens SR; Whitaker-Worth DL; Tong KB
J Am Acad Dermatol; 2003 Apr; 48(4):553-63. PubMed ID: 12664019
[TBL] [Abstract][Full Text] [Related]
16. Pimecrolimus: a review of its use in atopic dermatitis.
Wellington K; Noble S
Am J Clin Dermatol; 2004; 5(6):479-95. PubMed ID: 15663345
[TBL] [Abstract][Full Text] [Related]
17. Pimecrolimus: new preparation. Me-too: too many risks, not beneficial enough in atopic dermatitis.
Prescrire Int; 2004 Dec; 13(74):209-12. PubMed ID: 15599989
[TBL] [Abstract][Full Text] [Related]
18. Changing paradigms in dermatology: topical immunomodulators within a permutational paradigm for the treatment of atopic and eczematous dermatitis.
Abramovits W; Goldstein AM; Stevenson LC
Clin Dermatol; 2003; 21(5):383-91. PubMed ID: 14678718
[TBL] [Abstract][Full Text] [Related]
19. Non-steroidal topical immunomodulators provide skin-selective, self-limiting treatment in atopic dermatitis.
Bos JD
Eur J Dermatol; 2003; 13(5):455-61. PubMed ID: 14693489
[TBL] [Abstract][Full Text] [Related]
20. A randomized study of the safety, absorption and efficacy of pimecrolimus cream 1% applied twice or four times daily in patients with atopic dermatitis.
Ling M; Gottlieb A; Pariser D; Caro I; Stewart D; Scott G; Abrams K
J Dermatolog Treat; 2005 Aug; 16(3):142-8. PubMed ID: 16096179
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]